Image-guided Therapy Systems Market Size, Share & Trends Analysis Report By Product (Ultrasound, Computed Tomography Scanners), By Application (Cardiac Surgery, Neurosurgery), By End-use, By Region, And Segment Forecasts, 2023 - 2030
Image-guided Therapy Systems Market Growth & Trends
The global image-guided therapy systems market size is expected to reach USD 6.9 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to reach at a CAGR of 5.2% from 2023 to 2030. Growing geriatric population and increasing cases of chronic diseases are expected to boost the market demand. Other factors propelling the industry growth include rising preference for minimally invasive surgeries and technological advancements in image-guided therapy systems. Various initiatives undertaken in the area of cancer radiotherapy are driving the industry.
New product launches by major companies are also having a positive impact on market growth. For instance, in September 2020, Olympus Corporation launched ENDO-AID, an AI platform and endoscopy application with computer-aided detection for gastrointestinal applications. The AI platform with an endoscopy system-EVIS X1 enables real-time display. The growing adoption of such advanced systems is expected to drive the industry. The increasing number of initiatives undertaken by public and private firms in the area of cancer radiotherapy is also estimated to have a positive impact on industry growth.
Additionally, many academic institutions are investing in cancer radiotherapy projects for increasing the effectiveness of treatment therapies. This is also likely to contribute to market expansion. The development of the Image-guided Therapy Program by the Brigham and Women’s Hospital aimed at advancing imaging and therapeutic technologies for developing minimally invasive surgical and interventional techniques is an example of one such initiative.
Image-guided Therapy Systems Market Report Highlights
- North America accounted for the largest revenue share in 2022 owing to the rising geriatric population and high per capita expenditure
- Based on product, the endoscopes segment accounted for the largest revenue share in 2022 owing to technological advancements, high volume of endoscope-guided surgeries, and rising preference for minimally invasive surgeries
- On the basis of application, cardiac surgery emerged as the largest application segment in 2022 owing to factors such as rising prevalence of target diseases, preference for minimally invasive cardiac surgeries, and R&D initiatives aimed at developing real-time cardiac intervention systems
- By end-use, the hospitals segment accounted for the largest revenue share in 2022 as the hospital settings are equipped with technologically advanced devices
- The ambulatory surgery centers segment is projected to expand at the fastest CAGR of 5.9% over the forecast period
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. By Product
- 1.1.2. By Application
- 1.1.3. By End Use
- 1.1.4. Country scope
- 1.1.5. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR’s internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.6.2. Volume price analysis (Model 2)
- 1.6.2.1. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. End-use outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
- Chapter 3. Image-guided Therapy Systems Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.1.1. Rise in geriatric population and an increase in the burden of chronic diseases
- 3.3.1.2. Increase in number of initiatives for cancer radiotherapy
- 3.3.1.3. Technological advancements
- 3.3.1.4. Increase in preference for minimally invasive surgeries
- 3.3.2. Market restraint analysis
- 3.3.2.1. High price of image-guided therapy systems
- 3.4. Image-guided Therapy Systems Market Analysis Tools
- 3.4.1. Industry Analysis - Porter’s
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic landscape
- 3.4.3. Major deals & strategic alliances analysis
- 3.4.4. Market entry strategies
- Chapter 4. Image-guided Therapy Systems Market: By Product Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.1.1. Computed Tomography (CT) Scanners
- 4.1.2. Ultrasound Systems
- 4.1.3. Magnetic Resonance Imaging (MRI)
- 4.1.4. Endoscopes
- 4.1.5. X-ray Fluoroscopy
- 4.1.6. PET
- 4.1.7. SPECT
- 4.2. Product Market Share, 2022 & 2030
- 4.3. Segment Dashboard
- 4.4. Global Image-guided Therapy Systems Market, by Product Outlook
- 4.4.1. Computed Tomography (CT) Scanners
- 4.4.1.1. CT scanners market estimates and forecast, 2018 - 2030 (USD Million)
- 4.4.2. Ultrasound Systems
- 4.4.2.1. Ultrasound Systems market estimates and forecast, 2018 - 2030 (USD Million)
- 4.4.3. Magnetic Resonance Imaging (MRI)
- 4.4.3.1. Magnetic Resonance Imaging (MRI) market estimates and forecast, 2018 - 2030 (USD Million)
- 4.4.4. Endoscopes
- 4.4.4.1. Endoscopes market estimates and forecast, 2018 - 2030 (USD Million)
- 4.4.5. X-ray Fluoroscopy
- 4.4.5.1. X-ray Fluoroscopy market estimates and forecast, 2018 - 2030 (USD Million)
- 4.4.6. PET
- 4.4.6.1. PET market estimates and forecast, 2018 - 2030 (USD Million)
- 4.4.7. SPECT
- 4.4.7.1. SPECT market estimates and forecast, 2018 - 2030 (USD Million)
- Chapter 5. Image-guided Therapy Systems Market: By Application Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.1.1. Cardiac Surgery
- 5.1.2. Neurosurgery
- 5.1.3. Orthopedic Surgery
- 5.1.4. Urology
- 5.1.5. Gastroenterology
- 5.1.6. Oncology Surgery
- 5.1.7. Others
- 5.2. Application Market Share, 2022 & 2030
- 5.3. Segment Dashboard
- 5.4. Global Image-guided Therapy Systems Market, by Application Outlook
- 5.4.1. Cardiac surgery
- 5.4.1.1. Cardiac surgery market estimates and forecast, 2018 - 2030 (USD Million)
- 5.4.2. Neurosurgery
- 5.4.2.1. Neurosurgery market estimates and forecast, 2018 - 2030 (USD Million)
- 5.4.3. Orthopedic Surgery
- 5.4.3.1. Orthopedic surgery market estimates and forecast, 2018 - 2030 (USD Million)
- 5.4.4. Urology
- 5.4.4.1. Urology market estimates and forecast, 2018 - 2030 (USD Million)
- 5.4.5. Gastroenterology
- 5.4.5.1. Gastroenterology market estimates and forecast, 2018 - 2030 (USD Million)
- 5.4.6. Oncology Surgery
- 5.4.6.1. Oncology Surgery market estimates and forecast, 2018 - 2030 (USD Million)
- 5.4.7. Others
- 5.4.7.1. Others market estimates and forecast, 2018 - 2030 (USD Million)
- Chapter 6. Image-guided Therapy Systems Market: By End-use Estimates & Trend Analysis
- 6.1. Definitions and Scope
- 6.1.1. Hospitals
- 6.1.2. Specialty Clinics
- 6.1.3. Ambulatory Surgical Centers
- 6.1.4. Research and Academic Institutions
- 6.2. By End-use Market Share, 2022 & 2030
- 6.3. Segment Dashboard
- 6.4. Global Image-guided Therapy Systems Market by End-use Outlook
- 6.4.1. Hospitals
- 6.4.1.1. Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.2. Specialty clinics
- 6.4.2.1. Specialty clinics market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.3. Ambulatory surgical centers
- 6.4.3.1. Ambulatory surgical centers market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.4. Research and academic institutions
- 6.4.4.1. Research and academic institutions market estimates and forecast, 2018 - 2030 (USD Million)
- Chapter 7. Image-guided Therapy Systems Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Share Analysis, 2022 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Regional Market Snapshot
- 7.4. Regional Market Share and Leading Players, 2021
- 7.4.1. North America
- 7.4.2. Europe
- 7.4.3. Asia Pacific
- 7.4.4. Latin America
- 7.4.5. Middle East and Africa
- 7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
- 7.5.1. North America
- 7.5.2. Europe
- 7.5.3. Asia Pacific
- 7.5.4. Latin America
- 7.5.5. Middle East and Africa
- 7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2022 to 2030:
- 7.7. North America
- 7.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.2. U.S.
- 7.1.2.1. Key country dynamics
- 7.1.2.2. Competitive Scenario
- 7.1.2.3. Regulatory framework
- 7.1.2.4. Reimbursement scenario
- 7.1.2.5. U.S. market estimates and forecasts, 2018 - 2030
- 7.7.3. Canada
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory framework
- 7.7.3.4. Reimbursement scenario
- 7.7.3.5. Canada market estimates and forecasts, 2018 - 2030
- 7.2. Europe
- 7.2.1. UK
- 7.2.1.1. Key country dynamics
- 7.2.1.2. Competitive Scenario
- 7.2.1.3. Regulatory framework
- 7.2.1.4. Reimbursement scenario
- 7.2.1.5. UK market estimates and forecasts, 2018 - 2030
- 7.2.2. Germany
- 7.2.2.1. Key country dynamics
- 7.2.2.2. Competitive Scenario
- 7.2.2.3. Regulatory framework
- 7.2.2.4. Reimbursement scenario
- 7.2.2.5. Germany market estimates and forecasts, 2018 - 2030
- 7.2.3. France
- 7.2.3.1. Key country dynamics
- 7.2.3.2. Competitive Scenario
- 7.2.3.3. Regulatory framework
- 7.2.3.4. Reimbursement scenario
- 7.2.3.5. France market estimates and forecasts, 2018 - 2030
- 7.2.4. Italy
- 7.2.4.1. Key country dynamics
- 7.2.4.2. Competitive Scenario
- 7.2.4.3. Regulatory framework
- 7.2.4.4. Reimbursement scenario
- 7.2.4.5. Italy market estimates and forecasts, 2018 - 2030
- 7.2.5. Spain
- 7.2.5.1. Key country dynamics
- 7.2.5.2. Competitive Scenario
- 7.2.5.3. Regulatory framework
- 7.2.5.4. Reimbursement scenario
- 7.2.5.5. Spain market estimates and forecasts, 2018 - 2030
- 7.2.6. Denmark
- 7.2.6.1. Key country dynamics
- 7.2.6.2. Competitive Scenario
- 7.2.6.3. Regulatory framework
- 7.2.6.4. Reimbursement scenario
- 7.2.6.5. Denmark market estimates and forecasts, 2018 - 2030
- 7.2.7. Sweden
- 7.2.7.1. Key country dynamics
- 7.2.7.2. Competitive Scenario
- 7.2.7.3. Regulatory framework
- 7.2.7.4. Reimbursement scenario
- 7.2.7.5. Market estimates and forecasts, 2018 - 2030
- 7.2.8. Norway
- 7.2.8.1. Key country dynamics
- 7.2.8.2. Competitive Scenario
- 7.2.8.3. Regulatory framework
- 7.2.8.4. Reimbursement scenario
- 7.2.8.5. Norway market estimates and forecasts, 2018 - 2030
- 7.3. Asia Pacific
- 7.3.1. Japan
- 7.3.1.1. Key country dynamics
- 7.3.1.2. Competitive Scenario
- 7.3.1.3. Regulatory framework
- 7.3.1.4. Reimbursement scenario
- 7.3.1.5. Japan market estimates and forecasts, 2018 - 2030
- 7.3.2. India
- 7.3.2.1. Key country dynamics
- 7.3.2.2. Competitive Scenario
- 7.3.2.3. Regulatory framework
- 7.3.2.4. Reimbursement scenario
- 7.3.2.5. India market estimates and forecasts, 2018 - 2030
- 7.3.3. China
- 7.3.3.1. Key country dynamics
- 7.3.3.2. Competitive Scenario
- 7.3.3.3. Regulatory framework
- 7.3.3.4. Reimbursement scenario
- 7.3.3.5. China market estimates and forecasts, 2018 - 2030
- 7.3.4. South Korea
- 7.3.4.1. Key country dynamics
- 7.3.4.2. Competitive Scenario
- 7.3.4.3. Regulatory framework
- 7.3.4.4. Reimbursement scenario
- 7.3.4.5. South Korea market estimates and forecasts, 2018 - 2030
- 7.3.5. Australia
- 7.3.5.1. Key country dynamics
- 7.3.5.2. Competitive Scenario
- 7.3.5.3. Regulatory framework
- 7.3.5.4. Reimbursement scenario
- 7.3.5.5. Australia market estimates and forecasts, 2018 - 2030
- 7.3.6. Thailand
- 7.3.6.1. Key country dynamics
- 7.3.6.2. Competitive Scenario
- 7.3.6.3. Regulatory framework
- 7.3.6.4. Reimbursement scenario
- 7.3.6.5. Thailand market estimates and forecasts, 2018 - 2030
- 7.4. Latin America
- 7.4.1. Brazil
- 7.4.1.1. Key country dynamics
- 7.4.1.2. Competitive Scenario
- 7.4.1.3. Regulatory framework
- 7.4.1.4. Reimbursement scenario
- 7.4.1.5. Brazil market estimates and forecasts, 2018 - 2030
- 7.4.2. Mexico
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Competitive Scenario
- 7.4.2.3. Regulatory framework
- 7.4.2.4. Reimbursement scenario
- 7.4.2.5. Mexico market estimates and forecasts, 2018 - 2030
- 7.4.3. Argentina
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Competitive Scenario
- 7.4.3.3. Regulatory framework
- 7.4.3.4. Reimbursement scenario
- 7.4.3.5. Argentina market estimates and forecasts, 2018 - 2030
- 7.5. MEA
- 7.5.1. South Africa
- 7.5.1.1. Key country dynamics
- 7.5.1.2. Competitive Scenario
- 7.5.1.3. Regulatory framework
- 7.5.1.4. Reimbursement scenario
- 7.5.1.5. South Africa market estimates and forecasts, 2018 - 2030
- 7.5.2. Saudi Arabia
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory framework
- 7.5.2.4. Reimbursement scenario
- 7.5.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
- 7.5.3. UAE
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory framework
- 7.5.3.4. Reimbursement scenario
- 7.5.3.5. UAE market estimates and forecasts, 2018 - 2030
- 7.5.4. Kuwait
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Competitive Scenario
- 7.5.4.3. Regulatory framework
- 7.5.4.4. Reimbursement scenario
- 7.5.4.5. Kuwait market estimates and forecasts, 2018 - 2030
- Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.2.1. Innovators
- 8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key company market share analysis, 2022
- 8.3.4. Koninklijke Philips N.V.
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. Medtronic Plc.
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. Siemens Healthineers
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. Analogic Corporation
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. GE Healthcare
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. Varian Medical Systems, Inc.
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. Brainlab AG
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives
- 8.3.11. Olympus Corporation
- 8.3.11.1. Company overview
- 8.3.11.2. Financial performance
- 8.3.11.3. Product benchmarking
- 8.3.11.4. Strategic initiatives
- 8.3.12. Stryker
- 8.3.12.1. Company overview
- 8.3.12.2. Financial performance
- 8.3.12.3. Product benchmarking
- 8.3.12.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook